Trial Outcomes & Findings for Peer-Led Diet and Exercise Intervention (NCT NCT04994938)

NCT ID: NCT04994938

Last Updated: 2026-02-17

Results Overview

Cardiovascular endurance will be assessed with the distance covered during a six-minute walk test. The distance covered from baseline will be compared to post 12-week intervention.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

30 participants

Primary outcome timeframe

12-weeks

Results posted on

2026-02-17

Participant Flow

Both Peer Leaders and Participants were recruited and consented for this study. However, data was only collected for the 14 participants (who were studied), data was not collected for peer leaders.

Participant milestones

Participant milestones
Measure
Peer Led Diet and Exercise Intervention - All Study Participants
participation in two-times per week diet and exercise peer led interventions.
Overall Study
STARTED
30
Overall Study
Peer Leaders
9
Overall Study
Index Participants
14
Overall Study
COMPLETED
23
Overall Study
NOT COMPLETED
7

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Peer-Led Diet and Exercise Intervention

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Peer Led Diet and Exercise Intervention
n=14 Participants
participation in two-times per week diet and exercise peer led interventions.
Age, Categorical
<=18 years
0 Participants
n=25 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=25 Participants
Age, Categorical
>=65 years
14 Participants
n=25 Participants
Age, Continuous
76.3 years
STANDARD_DEVIATION 5.7 • n=25 Participants
Sex: Female, Male
Female
1 Participants
n=25 Participants
Sex: Female, Male
Male
13 Participants
n=25 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=25 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
13 Participants
n=25 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=25 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=25 Participants
Race (NIH/OMB)
Asian
0 Participants
n=25 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=25 Participants
Race (NIH/OMB)
Black or African American
7 Participants
n=25 Participants
Race (NIH/OMB)
White
7 Participants
n=25 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=25 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=25 Participants
Region of Enrollment
United States
14 Participants
n=25 Participants

PRIMARY outcome

Timeframe: 12-weeks

Population: Outcomes were collected only for the 14 participants, therefore, the results of this single are pilot study are reported and based on the 14 study participants and do not include Peer Leaders

Cardiovascular endurance will be assessed with the distance covered during a six-minute walk test. The distance covered from baseline will be compared to post 12-week intervention.

Outcome measures

Outcome measures
Measure
Peer Led Diet and Exercise Intervention
n=14 Participants
participation in two-times per week diet and exercise peer led interventions.
Change in Cardiovascular Endurance
20 yards
Standard Deviation 5

PRIMARY outcome

Timeframe: 12-weeks

Population: Outcomes were collected only for the 14 participants, therefore, the results of this single are pilot study are reported and based on the 14 study participants and do not include Peer Leaders

Food records will be gathered and analyzed using the automated self-administered recall system (ASA24) to evaluate diet quality. Results from baseline will be compared to those after 12 weeks of intervention. The Healthy Eating Index (HEI) is a summary score describing dietary quality on a 0-100 scale; higher scores indicate better diet quality.

Outcome measures

Outcome measures
Measure
Peer Led Diet and Exercise Intervention
n=14 Participants
participation in two-times per week diet and exercise peer led interventions.
Change in Diet Quality as Measured by the HEI Score
1.9 score on a scale of 100
Standard Deviation 2.4

SECONDARY outcome

Timeframe: 12-weeks

Population: Outcomes were collected only for the 14 participants, therefore, the results of this single are pilot study are reported and based on the 14 study participants and do not include Peer Leaders

The number of time and individuals can rise from a chair-without using their arms during a 30-second time period will be recorded and used as a measure of mobility. Results from baseline will be compared to those after 12-weeks of intervention.

Outcome measures

Outcome measures
Measure
Peer Led Diet and Exercise Intervention
n=14 Participants
participation in two-times per week diet and exercise peer led interventions.
Change in Mobility as Measured by the 30 Second Chair Stand Test
1.4 stands
Standard Deviation 0.7

Adverse Events

Peer Leader

Serious events: 0 serious events
Other events: 2 other events
Deaths: 2 deaths

Peer Led Diet and Exercise Intervention

Serious events: 2 serious events
Other events: 0 other events
Deaths: 2 deaths

Serious adverse events

Serious adverse events
Measure
Peer Leader
n=9 participants at risk
Peer leaders trained to lead the interventions two times per week
Peer Led Diet and Exercise Intervention
n=14 participants at risk
participation in two-times per week diet and exercise peer led interventions.
Cardiac disorders
Hospitalization
0.00%
0/9 • Adverse events were collected during participant's entire duration of study participation, which was 12 weeks.
The ClinicalTrials.gov definition of adverse events and serious adverse events was used to collect adverse event information.
7.1%
1/14 • Number of events 1 • Adverse events were collected during participant's entire duration of study participation, which was 12 weeks.
The ClinicalTrials.gov definition of adverse events and serious adverse events was used to collect adverse event information.
Cardiac disorders
Vertigo
0.00%
0/9 • Adverse events were collected during participant's entire duration of study participation, which was 12 weeks.
The ClinicalTrials.gov definition of adverse events and serious adverse events was used to collect adverse event information.
7.1%
1/14 • Number of events 1 • Adverse events were collected during participant's entire duration of study participation, which was 12 weeks.
The ClinicalTrials.gov definition of adverse events and serious adverse events was used to collect adverse event information.

Other adverse events

Other adverse events
Measure
Peer Leader
n=9 participants at risk
Peer leaders trained to lead the interventions two times per week
Peer Led Diet and Exercise Intervention
n=14 participants at risk
participation in two-times per week diet and exercise peer led interventions.
Infections and infestations
Positive COVID test
11.1%
1/9 • Number of events 1 • Adverse events were collected during participant's entire duration of study participation, which was 12 weeks.
The ClinicalTrials.gov definition of adverse events and serious adverse events was used to collect adverse event information.
0.00%
0/14 • Adverse events were collected during participant's entire duration of study participation, which was 12 weeks.
The ClinicalTrials.gov definition of adverse events and serious adverse events was used to collect adverse event information.
Cardiac disorders
SOB and Chest Pain
11.1%
1/9 • Number of events 1 • Adverse events were collected during participant's entire duration of study participation, which was 12 weeks.
The ClinicalTrials.gov definition of adverse events and serious adverse events was used to collect adverse event information.
0.00%
0/14 • Adverse events were collected during participant's entire duration of study participation, which was 12 weeks.
The ClinicalTrials.gov definition of adverse events and serious adverse events was used to collect adverse event information.

Additional Information

Dr. Odessa Addison

Baltimore VAMC

Phone: 410-605-7000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place